Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitations
- PMID: 22963172
- PMCID: PMC3449186
- DOI: 10.1186/1477-7819-10-184
Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitations
Abstract
Background: Surgery is still the standard treatment for aggressive fibromatosis (AF); however, local control remains a significant problem and the impact of R0 surgery on cumulative recurrence (CR) is objective of contradictory reports.
Methods: This is a single-institution study of 62 consecutive patients affected by extra-abdominal and intra-abdominal AF who received macroscopically radical surgery within a time period of 15 years.
Results: Definitive pathology examination confirmed an R0 situation in 49 patients and an R1 in 13 patients. Five-year CR for patients who underwent R0 vs R1 surgery was 7.1% vs 46.4% (P = 0.04) and for limbs vs other localizations 33.3% vs 9.9% (P = 0.02) respectively. In 17 patients who had intraoperative frozen section (IFS) margin evaluation R0 surgery was more common (17 of 17 vs 32 of 45, P = 0.01) and CR lower (five-year CR 0% vs 19.1%, respectively, P = 0.04). However, in multivariate analysis only limb localization showed a negative impact on CR (HR: 1.708, 95% CI 1.03 to 2.84, P = 0.04).
Conclusions: IFS evaluation could help the surgeon to achieve R0 surgery in AF. Non-surgical treatment, including watchful follow-up, could be indicated for patients with limb AF localization, because of their high risk of recurrence even after R0 surgery.
Figures
Similar articles
-
Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: Analysis of 114 patients at a single institution.Eur J Surg Oncol. 2015 Aug;41(8):1013-9. doi: 10.1016/j.ejso.2015.04.016. Epub 2015 May 13. Eur J Surg Oncol. 2015. PMID: 26005133
-
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.Cancer. 2013 Oct 15;119(20):3696-702. doi: 10.1002/cncr.28271. Epub 2013 Jul 31. Cancer. 2013. PMID: 23913621
-
Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis.Ann Surg Oncol. 2015 May;22(5):1464-70. doi: 10.1245/s10434-014-4156-x. Epub 2014 Oct 24. Ann Surg Oncol. 2015. PMID: 25341748
-
En bloc resection for intra-abdominal/retroperitoneal desmoid-type fibromatosis with adjacent organ involvement: A case series and literature review.Biosci Trends. 2018;12(6):620-626. doi: 10.5582/bst.2018.01285. Biosci Trends. 2018. PMID: 30674762 Review.
-
Margins in extra-abdominal desmoid tumors: a comparative analysis.J Surg Oncol. 2004 Jun 1;86(3):152-6. doi: 10.1002/jso.20057. J Surg Oncol. 2004. PMID: 15170654 Review.
Cited by
-
The Challenge in the Management of Extremity Fibromatoses: Our Experience.Indian J Surg Oncol. 2019 Jun;10(2):329-334. doi: 10.1007/s13193-018-0857-0. Epub 2018 Dec 13. Indian J Surg Oncol. 2019. PMID: 31168258 Free PMC article.
-
Recurrent aggressive mesenteric desmoid tumor successfully treated with sorafenib: A case report and literature review.World J Clin Oncol. 2019 Apr 24;10(4):183-191. doi: 10.5306/wjco.v10.i4.183. World J Clin Oncol. 2019. PMID: 31114750 Free PMC article.
-
Extra-abdominal desmoid tumor fibromatosis: a multicenter EMSOS study.BMC Cancer. 2021 Apr 20;21(1):437. doi: 10.1186/s12885-021-08189-6. BMC Cancer. 2021. PMID: 33879110 Free PMC article.
-
Abdominal wall reconstruction after desmoid type fibromatosis radical resection: Case series from a single institution and review of the literature.Int J Surg Case Rep. 2017;33:167-172. doi: 10.1016/j.ijscr.2017.02.050. Epub 2017 Mar 1. Int J Surg Case Rep. 2017. PMID: 28327422 Free PMC article.
-
Uncommon perineal tumours: caution with aggressive surgical management.BMJ Case Rep. 2013 Nov 15;2013:bcr2013200880. doi: 10.1136/bcr-2013-200880. BMJ Case Rep. 2013. PMID: 24243505 Free PMC article.
References
-
- Escobar C, Munker R, Thomas JO, Li BD, Burton GV. Update on desmoid tumors. Ann Oncol. 2011;23:562–569. - PubMed